Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma. - Wikidata - awgldk - TriplyDB

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma.

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma.

http://www.wikidata.org/entity/Q37708325

about

Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies.PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT.

P2860

Q42083096-C76CCD27-6254-4B76-B733-F446011D7C64 Q47109987-6B56BCFC-5188-4C96-B77C-51CF4E7DA285

P2860

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma.

http://www.wikidata.org/entity/Q37708325

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Veliparib in combination with ...... GMT unmethylated glioblastoma.

@en

Veliparib in combination with ...... GMT unmethylated glioblastoma.

@nl

type

label

Veliparib in combination with ...... GMT unmethylated glioblastoma.

@en

Veliparib in combination with ...... GMT unmethylated glioblastoma.

@nl

prefLabel

Veliparib in combination with ...... GMT unmethylated glioblastoma.

@en

Veliparib in combination with ...... GMT unmethylated glioblastoma.

@nl

P1433

Q37708325-C319E419-C201-4317-9D21-8C0355346C62

P1476

Q37708325-8BF25161-F955-445D-96A2-3639FD7BE1DB

P2093

Q37708325-2825E2E9-608C-4314-B04F-DC29EBE6C957

Q37708325-2D4BBF8B-2C22-4AB4-8ED3-363CA13CC102

Q37708325-6BF7AEE8-BE3D-4E18-B08F-0BBE346C65E8

Q37708325-87B48CAF-3A2E-4C28-B9BE-C4A1990CD69B

Q37708325-AE4E95B8-E261-4139-AFD5-C213C3C18FDD

Q37708325-C49AF972-D06F-48C6-9261-0B4A42B305DE

Q37708325-EA6F3956-5F0B-449C-B999-691498D166D7

Q37708325-FA8DE1BE-130D-4B27-AC15-ABE23E229A68

P2860

Q37708325-070F735B-BD1E-41EC-8097-A1BB1AAF151D

Q37708325-0C72588C-781A-456D-94C5-4977FED715C2

Q37708325-10621D47-F834-4346-8722-80B4EE66B0BF

Q37708325-11A24C90-D505-4790-B892-9B4616461ACA

Q37708325-1428633D-792B-42BD-A53D-895E0485A5C7

Q37708325-17ED71DF-82B6-4979-A687-A68E8032DE2F

Q37708325-22739B67-E662-43B1-BF40-F52754690AC1

Q37708325-318BBF5C-54E4-447E-BD3C-71DEEF1609D9

Q37708325-3F750EE1-2776-40E1-827E-20A88DFB865E

Q37708325-4BA03D05-16FC-4646-86D9-D8DB2F6D1D28

P2888

Q37708325-6B22F883-2B96-4321-ABD5-20D2AFFBF269

P304

Q37708325-8D65B9A9-3BF6-4A3D-855A-D025F2EDB653

P31

Q37708325-0977D4DB-EA59-4F50-B94E-225974A9DC34

P356

Q37708325-0752635C-9096-4DA9-930A-FB13143D7B7F

P433

Q37708325-5C7684A6-2093-4E96-8697-CD672AE7C61E

P478

Q37708325-AC4D7BD3-C894-4785-ABA8-C0205D94AB01

P50

Q37708325-146611BF-95E3-4B95-AC16-72839F8047CC

Q37708325-4FC20677-4399-4343-8EF5-D974B0272C10

P577

Q37708325-2A02543B-0CA5-4964-B3D2-E4D8FCF6422F

P6179

Q37708325-15630B10-2012-48C6-B306-019BADFB7805

P698

Q37708325-91199696-F5B3-4FFD-B7CF-54912650B0AF

P921

Q37708325-F0FB48B9-176D-4F7D-AC98-5CA19089ECE2

P932

Q37708325-447844E7-6DEE-45AA-A68C-06E3F1965A85

P356

S12967-017-1164-1

P1433

Journal of Translational Medicine

P1476

Veliparib in combination with ...... GMT unmethylated glioblastoma.

@en

P2093

Ashleigh J Lester

http://www.w3.org/2001/XMLSchema#string

Kerrie L McDonald

http://www.w3.org/2001/XMLSchema#string

Kyoko Nozue

http://www.w3.org/2001/XMLSchema#string

Lisette B W Schroder

http://www.w3.org/2001/XMLSchema#string

Robert W Rapkins

http://www.w3.org/2001/XMLSchema#string

Shane P Whittaker

http://www.w3.org/2001/XMLSchema#string

Sheri Nixdorf

http://www.w3.org/2001/XMLSchema#string

Swapna Joshi

http://www.w3.org/2001/XMLSchema#string

P2860

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Effect of MRE11 loss on PARP-inhibitor sensitivity in endometrial cancer in vitro

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment

Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts.

ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition.

Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer.

Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide.

P2888

s12967-017-1164-1

P304

61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-017-1164-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Mustafa Khasraw

P577

2017-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084251490

http://www.w3.org/2001/XMLSchema#string

P698

28314386

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5356284

http://www.w3.org/2001/XMLSchema#string